272BIO

Beeches Farm Road Maple Barn /

TN22 5QD Uckfield

GB

272BIO

Foundation date

19/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

272BIO are developing biotherapeutics, using innovative technologies, for livestock and companion animal disorders. Applying novel technologies, we are able to reduce hitherto prohibitive production costs and produce affordable therapies.  VHH antibodies enable 272BIO to design bespoke drugs for optimal disease control.

Upcoming events

Latest news

  • Biocartis and SkylineDx sign collaboration to develop the Merlin Assay

    23 hours ago

  • Biotalys appoints Simon Moroney as Chairman of the Board

    1 day ago

  • Celyad Oncology appoints Dr. Charles Morris as Chief Medical Officer

    Tuesday April 20th 2021